ORIGINAL RESEARCH
Accepted on 16 May 2025
Aumolertinib Plus Bevacizumab for Untreated Advanced NSCLC with EGFR Sensitive Mutation
doi 10.3389/fonc.2025.1595812
- 262 views
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Innovative Drug Combinations for Enhanced Solid Tumor Treatment Efficacy
Innovative Drug Combinations for Enhanced Solid Tumor Treatment Efficacy
542
Total downloads
3,143
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 16 May 2025
A trispecific antibody targeting EGFR/cMET/VEGF-A demonstrates multiple mechanisms of action to inhibit wild-type and mutant NSCLC animal models
doi 10.3389/fonc.2025.1533059
- 522 views
CASE REPORT
Published on 26 Feb 2025
Efficacy of anlotinib and chemotherapy combination as neoadjuvant therapy in the treatment of pulmonary artery intimal sarcoma: a case report
doi 10.3389/fonc.2025.1507281
- 536 views
SYSTEMATIC REVIEW
Published on 07 Jan 2025
Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis
doi 10.3389/fonc.2024.1515992
- 835 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.